A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia

Summary

This study will be conducted as a multi-center, open label study in the US. There will be 40 patient to receive the active investigational product.

Timeline

Start

2024-03-01

Primary completion

2025-06-15

Completion

2025-12-15

Outcome

Outcome not reported

Stopped: “Compound will not be studied for indication”

Drugs

Indications